• The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage - an observational study.

      Ahmed, S; Harrity, C; Johnson, S; Varadkar, S; McMorrow, S; Fanning, R; Flynn, C M; O' Riordan, J M; Byrne, B M; Department of Obstetrics and Gynaecology, Coombe Women and Infants University Hospital, Dublin, Ireland. (2012-10)
      Fibrinogen replacement is critical in major obstetric haemorrhage (MOH). Purified, pasteurised fibrinogen concentrate appears to have benefit over cryoprecipitate in ease of administration and safety but is unlicensed in pregnancy. In July 2009, the Irish Blood Transfusion Service replaced cryoprecipitate with fibrinogen.
    • The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity.

      Khalid, S; Dimitriou, E; Conroy, R; Paraskevaidis, E; Kyrgiou, M; Harrity, C; Arbyn, M; Prendiville, W; RCSI Department of Gynaecology, Coombe Women & Infants University Hospital, Dublin, Ireland. (2012-05)
      The aim of this study was to determine if the individual physical characteristics of the extirpated transformation zone after large loop excision of the transformation zone (LLETZ) might predict the relative risk of adverse obstetric outcome, specifically preterm labour (PTL).